Navigation Links
Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure
Date:9/17/2009

lable in two strengths as tablets containing aliskiren and valsartan: 150 mg/160 mg and 300 mg/320 mg.

Valturna is a prescription medication for adults containing two medicines in one tablet that work together to lower blood pressure when one is not enough. Valturna may also be used as the first medicine if your doctor decides you are likely to need more than one. Tekturna and Diovan may be used to treat high blood pressure. Tekturna may be used alone or in combination with other high blood pressure medicines. Tekturna has not been adequately studied in combination with the maximum doses of a class of medicines called ACE inhibitors.

Important Safety Information

IMPORTANT WARNING: Valturna, Tekturna, or Diovan may harm an unborn baby, causing injury and death. If you get pregnant, stop taking Valturna, Tekturna, or Diovan and call your doctor right away. If you plan to become pregnant, talk to your doctor about other medicines to treat your high blood pressure before taking Valturna, Tekturna, or Diovan.

Tell your doctor about all of your medical conditions, including kidney or liver problems. Also, tell your doctor about all medicines you take, including those to treat fungal infections, atorvastatin, cyclosporine, and potassium-containing medicines, supplements, or salt substitutes containing potassium.

If you develop an allergic reaction involving swelling of the face, lips, throat and/or tongue that may cause difficulty in breathing or swallowing, stop taking Valturna or Tekturna and contact your doctor immediately.

Your blood pressure may get too low if you also take water pills, are on a low-salt diet, get dialysis treatments, have heart problems, or get sick with vomiting or diarrhea. Lie down if you feel faint or dizzy. Call your doctor right away.

The most serious side effects with Diovan are low blood pre
'/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
2. Lifeclinic Supports the Novartis and International Association of Fire Fighters Campaign Against Hypertension
3. Video: Novartis Receives Approval From FDA to Market Prevacid(R) 24HR as First and Only OTC Proton Pump Inhibitor in Original Prescription Formulation
4. J&J, Schering-Plough, Novartis, Bayer vie for Top Honors at the Premier OTC / Healthcare Ad Awards
5. Novartis Oncology Launches GIST Alliance™ for Patients and Caregivers
6. Novartis Oncology Launches GIST Alliance™ for Healthcare Professionals Treating Gastrointestinal Stromal Tumors
7. Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration
8. Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity
9. Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients
10. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
11. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... September 19, 2014 -- Recent two-generation approaches to ... are receiving increasing attention from researchers, advocates, and ... to enable them to move to jobs that ... early care and education for children, these programs ... However, according to a new report from ...
(Date:9/19/2014)... As summer vacations end and everyone returns ... now reminds area patients about the reality and impact of ... affected by gum disease, there is simply not an option ... years Dr. Krishnan has treated patients with varying degrees of ... that come in due to common symptoms such as bleeding ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Recently, ... and announced that JustHost, IX Web Hosting and ... , “As is known to most people, ... partitioning a physical server computer into many servers, ... of running on someone’s own dedicated computer,” the ...
(Date:9/19/2014)... are notoriously difficult to study with X-ray crystallography, not ... impossible, to crystallize, but also because their very nature ... when a structure can be obtained it is often ... of protein domains that sometimes create more puzzles than ... Cryst . D70, 2241-2255; doi: 10.1107/S1399004714016496 ] , ...
(Date:9/19/2014)... 2014 Top10BestSEOHosting.com today compares many ... HostMonster, Arvixe and Bluehost are the best suppliers ... quality WordPress hosting (including VPS and cloud hosting) ... more detailed information. , HostMonster ( http://www.hostmonster.com/track/seohosts ) ... at a fraction of the cost. As a ...
Breaking Medicine News(10 mins):Health News:A two generation lens: Current state policies fail to support families with young children 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 3Health News:Top10BestSEOHosting.com: JustHost is One of the Best VPS Suppliers in 2014 2Health News:A refined approach to proteins at low resolution 2Health News:A refined approach to proteins at low resolution 3Health News:Top10BestSEOHosting.com: They Are Best Windows Web Hosting Suppliers Of 2014 2
... The international team of researchers from the United States and ... both assassin and messenger. This led to the // race ... cell. Cells that could seek out and destroy cancer have ... the Seraph Professor of Oncology at the Johns Hopkins Kimmel ...
... College of Georgia said that genes that control blood pressure ... on more than 500 pairs of black and // white ... that changes in gene expression between ages 14 and 18 ... variation that occurred by age 18. The results were presented ...
... in matters of sleep till late the reason being ... ray of new light comes the IST project 'Sensation' ... different // countries, addressing sensing of physiological parameters, core ... a multipurpose sensing platform consisting of 17 micro sensors ...
... in Mumbai were crippled as the striking doctors were determined ... dry. All the government hospitals in Mumbai suffered due to ... from 15 government-managed hospitals in this bustling city of over ... 27, demanding better security while on the job after relatives ...
... A research has found out that a sudden emotional stress ... beloved ones or failure// in romance are said to be ... ,Researchers at Johns Hopkins University found that shock could ... attack causing severe heart muscle weakness, reported health portal Health ...
... Center researchers have discovered that distinct regions of the ... ambiguous choices versus// choices involving only risk. The investigators ... and how such risk-taking can become an addition or ... in the journal Neuron. ,The research was ...
Cached Medicine News:Health News:Two in One Cell Offers Hope to Find a Cure for Cancer 2Health News:Genetic Reasons behind Change in One’s Blood Pressur 2Health News:Sleep Science awakens from deep slumber! 2Health News:Health Services Came To A Halt As Mumbai Doctors Strike Continues 2Health News:Distinct Brain Sections Are Activated While Making Risky Decisions 2
(Date:9/19/2014)... , Sept. 19, 2014 Intarcia ... interim clinical data for its lead candidate ITCA 650 ... patients with high baseline HbA1c levels at the 50 ... the Study of Diabetes (EASD). Data from the open-label, ... levels of blood sugar in patients with poorly controlled ...
(Date:9/18/2014)... DUBLIN , September 19, 2014 /PRNewswire/ ... and Markets ( http://www.researchandmarkets.com/research/qqjrnh/global_molecular ) has announced ... Cytogenetics Market 2014-2018" report to their ... ,Molecular Cytogenetics involves the study of chromosomes ... and functions of genes and chromosomes. It ...
(Date:9/18/2014)...  PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results ... June 30, 2014. Quarter Ended June ... 30, 2014 increased $492,000, or 18%, to $3.2 million ... 30, 2013, due primarily to an increase of $746,000 ... Company,s largest customer, partially offset by an aggregate decrease ...
Breaking Medicine Technology:Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 2Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 3Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 2Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 3Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 4Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 5Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 6Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 7Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 8Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 9Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 10Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 11Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 12Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 13
... May 7, 2012 A new analysis concludes that rituximab, ... treatment responses lasting at least five years in approximately one ... of bleeding due to chronic immune thrombocytopenic purpura (ITP). In ... Blood , the Journal of the American Society ...
... Mass., May 7, 2012  CardioFocus, Inc., developer of ... treatment of atrial fibrillation (AF), announces that its ... the scientific sessions and during a private academic ... Society,s 33rd Annual Scientific Sessions, May 9-12 in ...
Cached Medicine Technology:Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets 2Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets 3Worldwide Multicenter Experiences with CardioFocus HeartLight® EAS to be Presented at Heart Rhythm 2012 2Worldwide Multicenter Experiences with CardioFocus HeartLight® EAS to be Presented at Heart Rhythm 2012 3
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
Medicine Products: